Home » METABASIS THERAPEUTICS ANNOUNCES $41.3M PRIVATE PLACEMENT
METABASIS THERAPEUTICS ANNOUNCES $41.3M PRIVATE PLACEMENT
Metabasis Therapeutics, Inc. (Nasdaq: MBRX -- News) today announced that it raised approximately $41.3 million in a private placement of common stock and the concurrent issuance of warrants for the purchase of common stock. Under the terms of the financing, Metabasis sold approximately 7 million shares of common stock at $5.86 per share, the closing bid price for the company's common stock immediately preceding the entering into of the binding agreement for the transaction.
Yahoo News (http://biz.yahoo.com/prnews/051003/lam063.html?.v=24)
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
28Mar
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May